Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: controversial viewpoints and clinical perspectives.
Anxiety disorders are among the most frequent psychiatric disorders. Experimental evidence supports both psychotherapy as well as pharmacotherapy as effective treatments. There is, however, a controversy concerning the efficacy of a combination of both approaches. While some studies suggest that combined treatment enhances efficacy, others report conflicting results. This article traces the positions in this debate. We present the results from two recent meta-analyses and discuss implications for clinical practice and further research. We suggest that a research strategy that strives to establish differential indications based on patient characteristics should be preferred over attempts to reach a global judgement of the question, which appears too simplistic given the complexity of the issue.
Zwanzger
P
P
Department of Psychiatry and Psychotherapy, University of Munster, Albert-Schweitzer-Strasse 11, 49149 Munster, Germany. zwanzger@ukmuenster.de
Diemer
J
J
Jabs
B
B
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D015201:Meta-Analysis as Topic; D011613:Psychotherapy / Q000379:methods
D014151:Anti-Anxiety Agents